Optometrist · New York, NY
NPI
1023284833
Since 2008
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
203 E 121st St
New York, NY, 10035
Phone (212) 876-2957
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,454
176 services
Medicare patients, 2024
47
Average age 67
Drug cost, 2024
$857K
1,839 prescriptions
Company payments, 2025
$74.67
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aliya Hot was code 92250 (angiography), 38 times for 38 patients. In total Aliya Hot billed 176 services in 11 codes, and Medicare paid $9,454.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 38 | 38 | $30.43 | $1,156 |
| 92020 Ophthalmological E&M | Office | 32 | 32 | $16.62 | $532 |
| 92004 Ophthalmological E&M | Office | 25 | 25 | $114.37 | $2,859 |
| 92012 Ophthalmological E&M | Office | 19 | 17 | $79.52 | $1,511 |
| 92202 Ophthalmological E&M | Office | 16 | 14 | $13.47 | $216 |
| 92014 Ophthalmological E&M | Office | 12 | 12 | $86.23 | $1,035 |
By year: 2022 $14K for 243 services; 2023 $14K for 242 services; 2024 $9,454 for 176 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aliya Hot prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 511 prescriptions and refills. In total Aliya Hot wrote 1,839 Medicare prescriptions that cost $857K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 511 | 614 | 148 | $407K |
| Restasis Cyclosporine | 413 | 537 | 129 | $326K |
| Latanoprost Generic | 375 | 391 | 87 | $2,130 |
| Eysuvis Loteprednol Etabonate | 151 | 165 | 104 | $73K |
| Prednisolone Acetate Generic | 85 | 89 | 56 | $2,556 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 85 | 85 | 56 | $2,643 |
| Vyzulta Latanoprostene Bunod | 44 | 47 | 11 | $15K |
| Erythromycin Erythromycin Base | 26 | 26 | 15 | $258 |
| Cyclosporine Generic | 23 | 35 | 15 | $8,444 |
| Timolol Maleate Generic | 23 | 28 | Under 11 | $242 |
| Simbrinza Brinzolamide/Brimonidine Tart | 20 | 24 | Under 11 | $3,928 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 18 | 27 | Under 11 | $263 |
| Restasis Multidose Cyclosporine | 17 | 17 | Under 11 | $11K |
Brand drugs: 1,320 claims; generic drugs: 519 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aliya Hot $74.67 ($74.67 in general payments such as food, travel and fees) from 4 companies. The largest payer was Bausch & Lomb Americas Inc. with $20.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.